Literature DB >> 4006657

Prevalence and mortality of acute myocardial infarction in patients with diabetes.

L Rytter, S Troelsen, H Beck-Nielsen.   

Abstract

The purpose of this study was to investigate if insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM) predispose to the development of acute myocardial infarction (AMI) and modify the prognosis. The study includes 832 AMI patients consecutively hospitalized over a 3-yr period. The prevalence of diabetes mellitus among the AMI patients was 9.7% and is significantly higher than in an age-matched population, where it is 6.1% (P less than 0.001). The prevalence of diabetes was higher for women than for men (14.9% versus 7.6%). The risk of AMI was found to be twice as high among IDDM than among nondiabetic patients (P less than 0.001). Men with NIDDM were not found to have a significantly higher risk of AMI (P greater than 0.1), but the risk of AMI in women with NIDDM was approximately doubled (P less than 0.01). During the first month following AMI the mortality rate for nondiabetic patients was 20.2% compared with 42.0% for diabetic patients (P less than 0.001). Insulin treatment in NIDDM was associated with a reduced mortality rate compared with treatment with oral agents (P less than 0.05). The mortality rate was significantly higher in patients with poor metabolic control compared with patients in good control, whether before AMI or at the time of hospitalization. Diabetic patients had a higher risk of developing cardiogenic shock and conduction disorders than nondiabetic patients. We conclude that diabetes mellitus disposes to AMI and that the mortality rate of AMI is significantly increased among diabetic patients. Poor metabolic regulation of the diabetes may aggravate the prognosis for AMI.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006657     DOI: 10.2337/diacare.8.3.230

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

Review 1.  Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Authors:  J J Meier; B Gallwitz; W E Schmidt; A Mügge; M A Nauck
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

2.  Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.

Authors:  T Reffelmann; H G Klues; P Hanrath; E R Schwarz
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

3.  Five-year mortality after acute myocardial infarction in relation to previous history, level of initial care, complications in hospital, and medication at discharge.

Authors:  J Herlitz; A Bång; M Sjölin; B W Karlson
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 4.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

5.  The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus.

Authors:  A Dawson; A D Morris; A D Struthers
Journal:  Diabetologia       Date:  2005-08-11       Impact factor: 10.122

Review 6.  Diabetic cardiomyopathy: bench to bedside.

Authors:  Joel D Schilling; Douglas L Mann
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

7.  Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice.

Authors:  C Vecoli; J Cao; D Neglia; K Inoue; K Sodhi; L Vanella; K K Gabrielson; D Bedja; N Paolocci; A L'abbate; N G Abraham
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

Review 8.  Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

Authors: 
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

9.  Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.

Authors:  Charissa E van den Brom; Joanna W A M Bosmans; Ronald Vlasblom; Louis M Handoko; Marc C Huisman; Mark Lubberink; Carla F M Molthoff; Adriaan A Lammertsma; Margriet D Ouwens; Michaela Diamant; Christa Boer
Journal:  Cardiovasc Diabetol       Date:  2010-06-15       Impact factor: 9.951

10.  Long-Term Outcomes of Cardiac Rehabilitation in Diabetic and Non-diabetic Patients With Myocardial Infarction.

Authors:  Hyun Jun Kim; Min Cheol Joo; Se Eung Noh; Ji Hee Kim
Journal:  Ann Rehabil Med       Date:  2015-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.